Literature DB >> 25978951

Study on the anaphylactoid of three phenolic acids in Honeysuckle.

Fang Wang1, Cunyu Li2, Yunfeng Zheng2, Yu Li1, Guoping Peng3.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Chlorogenic acid (CA) is one of the major ingredients in Honeysuckle which exhibits anticancer, antibacterial, antiviral, hypoglycemic and anti-HIV activities. However, with the frequent emergence of anaphylactoid reactions of traditional Chinese medicine (TCM) injections which contains Honeysuckle in recent years, many researchers found that CA exhibited allergenicity. AIM OF THE STUDY: To explore the changes of content of CA, neochlorogenic acid (NCA) and cryptochlorogenic acid (CCA) during the preparation of Honeysuckle and evaluate the anaphylactoid of these three ingredients.
MATERIALS AND METHODS: Two extracts of Honeysuckle were prepared by different methods and the content of CA, NCA and CCA were determined by high performance liquid chromatography (HPLC) analysis. Guinea pig and mast cells RBL-2H3 were utilized as the animal and cell model to investigate the anaphylactoid of these three ingredients.
RESULTS: The content of CA decreased while CCA and NCA increased during the preparation of Honeysuckle. In vitro and in vivo studies showed that CA and CCA could significantly increase the plasma serotonin and β-hexosaminidase levels in guinea pigs and induce the degranulation of RBL-2H3 cell, while NCA did not show such properties. In addition, CAA had a stronger effect than CA.
CONCLUSION: We believed that both CA and CCA could cause anaphylactoid reaction while NCA could not. Moreover, the anaphylactoid of CCA is higher than CA. Our result demonstrated that CA is not the only cause of anaphylactoid reactions of TCM injections which contains Honeysuckle.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Anaphylactoid reaction; Chlorogenic acid; Chlorogenic acid (PubChem CID: 1794427); Cryptochlorogenic acid; Cryptochlorogenic acid (PubChem CID: 9798666); Honeysuckle; Methyl thiazolyl tetrazolium (PubChem CID: 16218671); Neochlorogenic acid; Neochlorogenic acid (PubChem CID: 5280633)

Mesh:

Substances:

Year:  2015        PMID: 25978951     DOI: 10.1016/j.jep.2015.05.011

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

1.  Allergens in red ginseng extract induce the release of mediators associated with anaphylactoid reactions.

Authors:  Lu Wang; Yazheng Zhao; Ye Yang; Yuanjia Hu; Xiaohan Zou; Boyang Yu; Jin Qi
Journal:  J Transl Med       Date:  2017-06-28       Impact factor: 5.531

2.  RhoA/ROCK Signaling Pathway Mediates Shuanghuanglian Injection-Induced Pseudo-allergic Reactions.

Authors:  Jiayin Han; Yong Zhao; Yushi Zhang; Chunying Li; Yan Yi; Chen Pan; Jingzhuo Tian; Yifei Yang; Hongyu Cui; Lianmei Wang; Suyan Liu; Jing Liu; Nuo Deng; Aihua Liang
Journal:  Front Pharmacol       Date:  2018-02-12       Impact factor: 5.810

3.  The Anti-Allergic Rhinitis Effect of Traditional Chinese Medicine of Shenqi by Regulating Mast Cell Degranulation and Th1/Th2 Cytokine Balance.

Authors:  Yang-Yang Shao; Yi-Ming Zhou; Min Hu; Jin-Ze Li; Cheng-Juan Chen; Yong-Jiang Wang; Xiao-Yun Shi; Wen-Jie Wang; Tian-Tai Zhang
Journal:  Molecules       Date:  2017-03-22       Impact factor: 4.411

4.  Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking.

Authors:  Ran Yu; Liang Chen; Rong Lan; Rong Shen; Peng Li
Journal:  Int J Antimicrob Agents       Date:  2020-05-08       Impact factor: 5.283

5.  Forsythoside A and Forsythoside B Contribute to Shuanghuanglian Injection-Induced Pseudoallergic Reactions through the RhoA/ROCK Signaling Pathway.

Authors:  Jiayin Han; Yushi Zhang; Chen Pan; Zhong Xian; Chenling Pan; Yong Zhao; Chunying Li; Yan Yi; Lianmei Wang; Jingzhuo Tian; Suyan Liu; Dunfang Wang; Jing Meng; Aihua Liang
Journal:  Int J Mol Sci       Date:  2019-12-12       Impact factor: 5.923

6.  Compound-honeysuckle-induced drug eruption with special manifestations: A case report.

Authors:  Li-Feng Zhou; Rong Lu
Journal:  World J Clin Cases       Date:  2022-08-06       Impact factor: 1.534

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.